Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Introduction of Integra(R) Hollywood(TM) NanoMetalene(TM) Interbody Device
Company's First Spinal Implant Using Proprietary NanoMetalene Coating Technology
View HTML
Toggle Summary Integra LifeSciences Announces Instrument Repair Partnership With InstruMedics
PLAINSBORO, N.J., April 14, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced a partnership with InstruMedics LLC., a national provider of service and repair for surgical instruments and equipment. The relationship will allow Integra's Surgical Instrument
View HTML
Toggle Summary Integra LifeSciences Announces Initial Clinical Use of the Cadence™ Total Ankle System in the United States
PLAINSBORO, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first ten procedures using the Integra® Cadence TM Total Ankle System were successfully completed by Dr.
View HTML
Toggle Summary Integra LifeSciences Announces In-Kind Donation of Over $1 Million in Medical Instruments to Direct Relief International
PLAINSBORO, N.J., Feb 18, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) completed an in-kind donation of over $1 million worth of medical instruments and devices to Direct Relief International, a non-profit, non-sectarian humanitarian
View HTML
Toggle Summary Integra LifeSciences Announces Full Market Release for the Integra(R) Freedom Wrist Arthroplasty System
PLAINSBORO, N.J., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full commercial release of the Integra® Freedom Wrist Arthroplasty System in the United States. The system, which is used in the treatment of wrist arthritis, has been
View HTML
Toggle Summary Integra LifeSciences Announces FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra(R) Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
Results Accepted for Publication in Wound Repair and Regeneration
View HTML
Toggle Summary Integra LifeSciences Announces First Two-Level Surgery With Paramount(R) Pedicle Screw System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first two-level surgery using the Paramount® Pedicle Screw System for minimally invasive spine surgery under Integra Spine's ownership was performed by Dr.
View HTML
Toggle Summary Integra LifeSciences Announces First Surgery With Paramount(R) Pedicle Screw System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first surgery using Integra Spine's Paramount(R) Pedicle Screw System for minimally invasive spine surgery was performed by Dr. Andrew Parkinson, of Orthopedic Associates of Oklahoma
View HTML
Toggle Summary Integra LifeSciences Announces First Surgery With Coral Spinal System for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Jan. 22, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today that the first clinical application of the Coral™ Spinal System for minimally invasive spine surgery was performed by Dr. Morteza Farr from Santa Cruz, California. Dr.
View HTML
Toggle Summary Integra LifeSciences Announces First Quarter 2004 Financial Results
Integra LifeSciences Announces First Quarter 2004 Financial Results PLAINSBORO, N.J., April 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.4 million, or $0.24 per share, for the first quarter of 2004, compared to net income of $5.4
View HTML